Skip to main navigation Skip to search Skip to main content

Design, history and results of the Thiazolidinedione Intervention with vitamin D Evaluation (TIDE) randomised controlled trial

Z Punthakee, J Bosch, G Dagenais, Ricardo Gredilla Diaz, R Holman, J L Probstfield, A Ramachandran, M C Riddle, L E Rydén, B Zinman, R Afzal, S Yusuf, H C Gerstein, TIDE Trial Investigators

    55 Citations (Scopus)

    Abstract

    AIMS/OBJECTIVE: Conflicting data regarding cardiovascular effects of thiazolidinediones (TZDs) and extra-skeletal effects of vitamin D supported the need for a definitive trial. The Thiazolidinedione Intervention with vitamin D Evaluation (TIDE) trial aimed to assess the effects of TZDs (rosiglitazone and pioglitazone) on cardiovascular outcomes and the effects of vitamin D (cholecalciferol) on cancers and mortality.
    Original languageEnglish
    JournalDiabetologia
    Volume55
    Issue number1
    Pages (from-to)36-45
    Number of pages10
    ISSN0012-186X
    DOIs
    Publication statusPublished - Jan 2012

    Keywords

    • Aged
    • Cardiovascular Diseases
    • Cholecalciferol
    • Combined Modality Therapy
    • Diabetes Mellitus, Type 2
    • Dietary Supplements
    • Dose-Response Relationship, Drug
    • Double-Blind Method
    • Early Termination of Clinical Trials
    • Female
    • Humans
    • Hypoglycemic Agents
    • Incidence
    • Male
    • Middle Aged
    • Neoplasms
    • Risk Factors
    • Thiazolidinediones

    Fingerprint

    Dive into the research topics of 'Design, history and results of the Thiazolidinedione Intervention with vitamin D Evaluation (TIDE) randomised controlled trial'. Together they form a unique fingerprint.

    Cite this